Hemostatic Profile and Serological Response of Patients with Immune Thrombotic Thrombocytopenic Purpura after Receiving BNT162b2 Vaccine: A Prospective Study.

Francesca SchieppatiLaura RussoSara GambaElisa GalimbertiCinzia GiaccheriniCarmen J TartariSilvia BologniniCristina VerzeroliChiara TicozziLuca BarcellaMarina MarchettiAnna Falanga

Published in: Thrombosis and haemostasis (2023)

The results of this study are in favor of efficacy and safety of mRNA vaccines in patients with iTTP, and highlight the importance of long-term monitoring of iTTP patients.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
binding protein